SCHEMBL194549

SCHEMBL194549

C=CC(=O)NCC(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
CYP3A4 P08684 3/20 0.52
HPGD P15428 3/20 0.52
MAPT P10636 3/20 0.52
MAPK1 P28482 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
ALOX15 P16050 1/20 0.52
CES1 P23141 1/20 0.52
ALDH1A1 P00352 10/20 0.51
ALOX12 P18054 1/20 0.51
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 1/20 0.49
TGM2 P21980 1/20 0.48
AKT1 P31749 1/20 0.48
PTPN1 P18031 2/20 0.46
ERCC5 P28715 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15338471 0.83 MEN1 (0.54) MEN1KMT2ACYP3A4HPGDMAPT
SCHEMBL3828720 0.82 TGM2 (0.51) MEN1KMT2ACYP3A4HPGDMAPT
SCHEMBL195429 0.82 ALDH1A1 (0.49) MEN1KMT2AMAPTMAPK1KDM4E
SCHEMBL28102384 0.81 MEN1 (0.52) MEN1KMT2ACYP3A4HPGDMAPT
SCHEMBL2923972 0.80 MEN1 (0.48) MEN1KMT2AHPGDMAPTSMN1; SMN2
SCHEMBL8440872 0.80 ALDH1A1 (0.59) MEN1KMT2ACYP3A4HPGDMAPT
SCHEMBL23023262 0.79 ALDH1A1 (0.50) MEN1KMT2ACYP3A4HPGDMAPT
SCHEMBL11756979 0.79 ALDH1A1 (0.57) MEN1KMT2ACYP3A4HPGDMAPT
SCHEMBL23014245 0.78 ALDH1A1 (0.46) HPGDMAPTMAPK1SMN1; SMN2KDM4E
SCHEMBL11216066 0.78 MEN1 (0.62) MEN1KMT2ACYP3A4HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150924-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND CELLGENTEK CO., LTD. (KR) 2023-05-18 US claimed
EP-4019495-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND Cellgentek Co., Ltd (KR) 2022-06-29 EP claimed
WO-2021034087-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND 주식회사 셀젠텍 2021-02-25 WO claimed
WO-2024134400-A1 MOISTURE-PERMEABLE HOT MELT PROCESSABLE MEDICAL ADHESIVES SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2024-06-27 WO disclosed
CN-118103205-A Multilayer pressure sensitive adhesive assembly and related method 3M创新有限公司 2024-05-28 CN disclosed
WO-2023203402-A1 LONG TERM WEARABLE MEDICAL PRESSURE SENSITIVE ADHESIVE ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-10-26 WO disclosed
US-20230150924-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND CELLGENTEK CO., LTD. (KR) 2023-05-18 US disclosed
US-20230150924-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND CELLGENTEK CO., LTD. (KR) 2023-05-18 US disclosed
EP-4019495-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND Cellgentek Co., Ltd (KR) 2022-06-29 EP disclosed
EP-4019495-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND Cellgentek Co., Ltd (KR) 2022-06-29 EP disclosed
US-11209733-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-20020020832-A1 Photosensitive resin composition CIBA SPECIALTY CHEMICALS CORP. 2002-02-21 US disclosed
US-20010012596-A1 For resist applications; thermostability, storage stability CIBA SPECIALTY CHEMICALS CORP. 2001-08-09 US disclosed
WO-2000078885-A1 WET-STICK ADHESIVES 3M INNOVATIVE PROPERTIES COMPANY (US) 2000-12-28 WO disclosed
EP-0922715-A2 Stimuli-responsive polymer utilizing keto-enol tautomerization AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) 1999-06-16 EP disclosed
EP-0886672-A1 METHODS OF MAKING VISCOELASTIC COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-12-30 EP disclosed
WO-1997033945-A1 METHODS OF MAKING VISCOELASTIC COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-09-18 WO disclosed
US-5663212-A Light-sensitive resin composition FUJI PHOTO FILM CO., LTD. (JP) 1997-09-02 US disclosed
EP-0779853-A1 METHOD OF MAKING A PACKAGED HOT MELT ADHESIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-06-25 EP disclosed
WO-1996007522-A1 METHOD OF MAKING A PACKAGED HOT MELT ADHESIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150924-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND KNTC1, MED1, LEF1 MEN1 410/4885KMT2A 793/4885CYP3A4 3107/4885
US-11209733-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 MEN1 2400/4885KMT2A 2024/4885CYP3A4 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.